UBS Group
ACHC icon

UBS Group’s Acadia Healthcare ACHC Stock Holding History

UBS Group’s Portfolio ACHC Stock Details ACHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$66.3M Buy
2,833,862
+855,771
+43% +$15.5M 0.01% 1364
2025
Q4 		$28.1M Sell
1,978,091
-2,358,607
-54% -$44.6M ﹤0.01% 2250
2025
Q3 		$107M Buy
4,336,698
+350,484
+9% +$7.82M 0.02% 982
2025
Q2 		$90.4M Buy
3,986,214
+2,816,384
+241% +$66.7M 0.02% 1036
2025
Q1 		$35.5M Buy
1,169,830
+480,235
+70% +$18.3M 0.01% 1791
2024
Q4 		$27.3M Buy
689,595
+60,878
+10% +$2.75M 0.01% 2000
2024
Q3 		$39.9M Buy
628,717
+418,691
+199% +$30.2M 0.01% 1319
2024
Q2 		$14.2M Buy
210,026
+169,219
+415% +$11.8M ﹤0.01% 1953
2024
Q1 		$3.23M Buy
40,807
+26,242
+180% +$2.15M ﹤0.01% 3433
2023
Q4 		$1.13M Sell
14,565
-37,049
-72% -$2.74M ﹤0.01% 4390
2023
Q3 		$3.63M Sell
51,614
-9,626
-16% -$719K ﹤0.01% 2884
2023
Q2 		$4.88M Sell
61,240
-38,259
-38% -$2.76M ﹤0.01% 2619
2023
Q1 		$7.19M Buy
99,499
+39,394
+66% +$3.07M ﹤0.01% 2177
2022
Q4 		$4.95M Buy
60,105
+26,992
+82% +$2.23M ﹤0.01% 2512
2022
Q3 		$2.59M Sell
33,113
-23,015
-41% -$1.84M ﹤0.01% 2931
2022
Q2 		$3.8M Buy
56,128
+31,203
+125% +$2.18M ﹤0.01% 2605
2022
Q1 		$1.63M Sell
24,925
-78,287
-76% -$4.55M ﹤0.01% 3636
2021
Q4 		$6.26M Buy
103,212
+22,851
+28% +$1.36M ﹤0.01% 2587
2021
Q3 		$5.13M Sell
80,361
-25,294
-24% -$1.6M ﹤0.01% 2646
2021
Q2 		$6.63M Buy
105,655
+14,648
+16% +$919K ﹤0.01% 2406
2021
Q1 		$5.2M Buy
91,007
+42,393
+87% +$2.29M ﹤0.01% 2556
2020
Q4 		$2.44M Sell
48,614
-46,862
-49% -$1.87M ﹤0.01% 3210
2020
Q3 		$2.81M Buy
95,476
+54,962
+136% +$1.6M ﹤0.01% 2733
2020
Q2 		$1.02M Buy
40,514
+2,148
+6% +$53.6K ﹤0.01% 3496
2020
Q1 		$704K Sell
38,366
-73,929
-66% -$2.12M ﹤0.01% 3669
2019
Q4 		$3.73M Buy
112,295
+25,426
+29% +$797K ﹤0.01% 2887
2019
Q3 		$2.7M Sell
86,869
-8,654
-9% -$264K ﹤0.01% 3002
2019
Q2 		$3.34M Buy
95,523
+19,415
+26% +$628K ﹤0.01% 2677
2019
Q1 		$2.23M Buy
76,108
+39,768
+109% +$1.13M ﹤0.01% 2899
2018
Q4 		$934K Sell
36,340
-1,937
-5% -$67K ﹤0.01% 3741
2018
Q3 		$1.35M Sell
38,277
-13,521
-26% -$539K ﹤0.01% 3567
2018
Q2 		$2.12M Sell
51,798
-24,940
-33% -$1.01M ﹤0.01% 3112
2018
Q1 		$3.01M Buy
76,738
+36,045
+89% +$1.32M ﹤0.01% 2768
2017
Q4 		$1.33M Sell
40,693
-9,640
-19% -$334K ﹤0.01% 3532
2017
Q3 		$2.4M Sell
50,333
-3,388
-6% -$165K ﹤0.01% 2957
2017
Q2 		$2.65M Buy
53,721
+16,092
+43% +$713K ﹤0.01% 2744
2017
Q1 		$1.64M Buy
37,629
+9,800
+35% +$398K ﹤0.01% 3119
2016
Q4 		$922K Sell
27,829
-84,983
-75% -$3.3M ﹤0.01% 3609
2016
Q3 		$5.59M Buy
112,812
+11,462
+11% +$597K ﹤0.01% 1924
2016
Q2 		$5.62M Sell
101,350
-9,670
-9% -$566K ﹤0.01% 1846
2016
Q1 		$6.12M Sell
111,020
-7,856
-7% -$448K ﹤0.01% 1701
2015
Q4 		$7.42M Sell
118,876
-105,066
-47% -$6.84M ﹤0.01% 1643
2015
Q3 		$14.8M Buy
223,942
+202,423
+941% +$15.6M 0.01% 1092
2015
Q2 		$1.69M Buy
21,519
+7,341
+52% +$528K ﹤0.01% 3137
2015
Q1 		$1.01M Buy
14,178
+4,417
+45% +$283K ﹤0.01% 3564
2014
Q4 		$597K Buy
+9,761
New +$568K ﹤0.01% 4032

Other funds holding ACHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ABI
Abrams Bison Investments Bethesda, Maryland $2.31B AUM 40.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

UBS Group's ACHC Position: Q1 2026 in Review

UBS Group increased its Acadia Healthcare (ACHC) stake by 43% in Q1 2026, buying an estimated $15.5M and bringing the position to 2,833,862 shares worth $66.3M. The position accounts for 0.01% of the portfolio, ranked #1364.

UBS Group first reported a position in ACHC in Q4 2014 and has held it in 46 quarters since. The position peaked at $107M in Q3 2025. 295 funds tracked by Wall St. Rank hold ACHC as of Q1 2026.

  • UBS Group held 2,833,862 shares of Acadia Healthcare worth $66.3M as of Q1 2026.
  • UBS Group bought 855,771 Acadia Healthcare shares in Q1 2026, an estimated $15.5M.
  • Acadia Healthcare made up 0.01% of UBS Group's portfolio in Q1 2026, its #1364 holding.
  • UBS Group first reported a position in Acadia Healthcare in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Acadia Healthcare position peaked at $107M in Q3 2025.
  • 295 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.